EDE. Diot

E. Diot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. Diot has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 14 September 2015
      • Vol. 32  (3) , 275-7

    Pulmonary manifestations revealing Rosai-Dorfman disease.

    by J Goupil De Bouillé, A De Muret, E Diot, P Dumont, L Plantier, P Diot, Sylvain Marchand-Adam

    Rosai-Dorfman disease is a rare non-Langerhans cell histiocytosis, mainly involving cervical nodes. We present the case of a patient with a pulmonary form of Rosai-Dorfman disease without peripheral or intra-thoracic lymph nodes, characterized by the presence of pulmonary nodules and cysts associated with bilateral pleural effusions.


  • Manifestations pulmonaires révélatrices d’une maladie de Rosai Dorfman

    by M. Campana, J. Goupil, A. De Muret, E. Diot, S. Marchand-Adam

    • 25 November 2013
      • Vol. 30  (3) , 231-6

    Chronic bronchiolitis in ankylosing spondylitis.

    by D Marquette, E Diot, A De Muret, C Blechet, O Favelle, A Sonneville, S Mammou, P Dumont, P Diot, S Marchand-Adam

    The pleuro-pulmonary signs of ankylosing spondylitis are generally asymptomatic, typically represented by biapical lung fibrosis. To our knowledge, the severe bronchiolitis which is sometimes observed in other spondyloarthropathies has not been described in ankylosing spondylitis. We report two cases of severe chronic bronchiolitis in ankylosing spondylitis patients. Their clinical and radiological presentation were similar, characterized by progressive deterioration of stage III-IV dyspnea, non-reversible obstructive ventilatory defect, and CT scan showing air trapping with mosaic attenuation and ground-glass opacity in expiration. Lung biopsies confirmed the diagnosis of severe follicular bronchiolitis in one patient and constrictive bronchiolitis is suspected in the other. Only the patient with follicular bronchiolitis responded positively to treatment with low doses of macrolides.

    • 1 November 2002
      • Vol. 58, 290-5

    [Bronchectasia and microscopic polyangeitis].

    by J-C Koninck, E Diot, E Hazouard, M-C Machet, J-F Valentin, E Lemarie, P Diot

    Microscopic polyangeitis is a necrosing vascularitis with pulmonary and renal tropism. Localized in the lung, microscopic polyangeitis leads to intra-alveolar hemorrhage. We report our observations in two patients who presented with concomitant bronchectasia. The parallel course of these two conditions suggests a possible relationship. We propose a pathophysiological approach involving a direct role of polymorphonuclear neutrophils and neutrophilic proteases secreted in response to activation of anti-polymorphonuclear cytoplasm anti-bodies (ANCA) during microscopic polyangeitis aggravating bronchectasia.

    • 1 December 2000
      • Vol. 17  (6) , 1073-80

    [Strategy for early diagnosis of lung involvement in systemic scleroderma].

    by E Diot, C Valat, E Boissinot, B Giraudeau, E Asquier, J L Guilmot, E Lemarié, P Diot

    Systemic sclerosis (SSc) is an autoimmune disorder characterized by accumulation of collagen in affected organs, mainly the skin and the lungs, associated with abnormalities of the arterioles and capillaries. There are two types of pulmonary involvement, which influence long term prognosis: infiltration of the lungs and/or pulmonary artery hypertension. Full investigations into possible lung involvement must be performed systematically when SSc is diagnosed and during follow-up. The double pathophysiology sometimes makes diagnosis difficult but it must be made as early as possible in order to decide on the optimal treatment. The aim of this study was to evaluate the usual explorations and to propose biological markers to identify patients requiring more detailed lung investigations, in order to establish a diagnostic approach to treatment and follow-up patients with SSc.

    • 1 September 2000
      • Vol. 56  (4) , 265-8

    [Wegener's disease mimicking acute infectious pleurisy].

    by E Diot, C Lavigne, L Renjard, E Asquier, J F Valentin, A Legras, J L Guilmot, E Lemarié, P Diot

    A 75-year-old woman followed for Wegener's disease was hospitalized for pleural effusion. The clinical presentation and cytology of the pleural fluid suggested the diagnosis of purulent pleurisy in this immunodepressed patient. The final diagnosis was a pleural involvement of Wegener's disease, a rarely described localization, as proven by the typical pathology findings.


    • 1 June 1999
      • Vol. 16  (3) , 277-85

    [Anti-infective aerosols].

    by P Diot, P F Dequin, B Rivoire, F Gagnadoux, F Faurisson, E Diot, E Boissinot, E Lemarié

    Anti-infectious agents such as pentamidine, antibiotics (mainly colistine and aminoglycosides) and amphotericin B can be administered by aerosol. This route of administration is not officially approved and it constitutes an empirical approach which has benefited from recent research which is summarized hereafter. The most fundamental question is related to the potentially deleterious effects of nebulization processes, especially ultrasound, on the anti infectious properties of the drugs. Colimycin, which was chosen as a reference because its polypeptide structure makes it unstable a priori, proved to be resistant to high frequency ultrasound, which is encouraging for other molecules such as aminoglycosides or betalactamins. The nebulizer characteristics have also to be taken into account. An aerosol can be produced from an amphotericin B suspension and from colistine using both an ultrasonic nebulizer and a jet nebulizer. Distinction between good and bad nebulizers does not depend upon the physical process involved to nebulize the drug, but on the intrinsic characteristics of the device and its performance with a known drug. The inhaled mass of an aerosol in the respirable range must be high and dosimetric nebulizers represent a significant progress. Finally, adminnistration of anti infectious aerosols requires a new pharmacological approach to monitor treatment and urinary assays are promising.

    • 1 January 1992
      • Vol. 9  (2) , 139-43

    [Pleuro-pulmonary manifestation of pancreatic diseases].

    by M Lavandier, P Diot, A Schwartz, L Kouyoumdjian, E Diot

    Non-neoplastic pancreatic disorders may cause pleuro-pulmonary signs. In acute pancreatitis respiratory disorders are very frequent and may cause simply an hypoxia or the adult respiratory distress syndrome (SDRA). There is no single mechanism: mechanical hypoventilation, alteration of the vessel walls and interstitial oedema, stasis of leucocytes, alterations in surfactant and intravascular coagulation may all contribute. These disturbances may be made by direct action of enzymes or by the intermediary of the activation of the kinine system, of complement activation and of coagulation mechanisms. In chronic pancreatitis the problem is to diagnose the cause of the pleural effusion which may often appear to be primary. The cause is suggested by a raised pleural amylase, type P. Although neoplastic pleural effusions may sometimes be rich in amylase it is of type S. The diagnosis rests on echos, computerised scans and retrograde cholangeopancreatography. The pathophysiology of these effusions is through the passage on the enzymes by the lymphatic route, by the oesophageal and aortic route or by a pancreatico-pleural fistula.


    • 1 January 1990
      • Vol. 7  (1) , 65-8

    [Steroid-sensitive cavitating pulmonary opacity in Horton's disease].

    by E Diot, P Diot, G Lasfargues, J P Renard, P LeComte, E Lemarie, M Lavandier, J L Guilmot

    We report the case of a 72 year old woman treated for seven months for Horton's disease presenting with a cavitating pneumonia of the left axillary segment associated with a deterioration of the general state, at the time of which the steroid therapy was in the course of being decreased. The radiological appearance and the clinical context of immune depression had led to a trial of a quadruple anti-tuberculous therapy in spite of the absence of any bacteriological proof. This rapid aggravation of the condition under treatment led to the suggestion of a pulmonary localisation of Horton's disease. The rapid regression of the lesions after increasing the dose of steroids and the negative cultures on Lowenstein medium pleaded in favour of this hypothesis. However the continuation of anti-tuberculous treatment seems justified in such cases in so far as the diagnosis of Horton's disease of the lung often cannot be maintained other than retrospectively in the absence of histological proof.